Doah Cho
Camperdown, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials.
Journal: JCO precision oncology
Published: January 08, 2024
Criteria for assessing evidence for biomarker-targeted therapies in rare cancers-an extrapolation framework.
Journal: Therapeutic advances in medical oncology
Published: December 14, 2023
Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance.
Journal: BMJ open
Published: July 12, 2022
Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework.
Journal: Therapeutic advances in medical oncology
Published: February 04, 2022
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis.
Journal: JAMA network open
Published: September 08, 2020
Benchmarking single-arm studies against historical controls from non-small cell lung cancer trials - an empirical analysis of bias.
Journal: Acta oncologica (Stockholm, Sweden)
Published: October 15, 2019
Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-Analysis.
Journal: JCO precision oncology
Published: November 01, 2017
'A most malignant malady': a rare case of laryngeal tuberculosis in epidermal growth factor receptor mutant lung adenocarcinoma.
Journal: Internal medicine journal
Published: December 10, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026